双靶向嵌合肽PMF选择性抗变异链球菌生物膜
本研究设计并合成嵌合肽PMF,整合三个功能域以实现菌种选择性抗菌及抗生物膜活性,并评估其溶血毒性、对浮游菌和生物膜的抗菌作用及机制。结果显示PMF对变异链球菌MIC/MBC为1.56/3.13 μM,而对共生链球菌MIC>100 μM,机制涉及静电结合膜脂导致膜损伤及破坏EPS,为下一代靶向防龋治疗提供框架。
要点
- PMF对变异链球菌MIC/MBC为1.56/3.13 μM,对共生链球菌MIC>100 μM。
- 25 μM处理15分钟抑制4小时生物膜生长且不影响共生菌生长。
- PMF通过静电结合膜脂破坏膜完整性及EPS发挥双靶向作用。
核心结论
- 双靶向肽PMF实现精准清除变异链球菌并维持微生态平衡。
研究设计与样本
- 化学合成抗菌肽并评估其溶血毒性、细胞毒性、抗浮游菌及抗生物膜活性。
- 通过MIC、MBC、时间杀菌动力学和活死染色测定抗浮游菌活性。
- 通过生物膜成像、抗生物膜后效应和结晶紫定量评估抗生物膜特性。
主要发现
- PMF对变异链球菌MIC/MBC=1.56/3.13 μM,对血链球菌和戈登链球菌MIC>100 μM。
- 25 μM处理15分钟抑制4小时生物膜生长且不影响共生菌生长。
- 时间杀菌试验显示PMF优于氯己定(CHX)。
- 对24小时生物膜,PMF破坏效率优于CHX且在亚MIC剂量下抑制生物膜形成。
- 机制上PMF通过静电作用结合细菌膜脂,破坏膜完整性致浮游菌核酸泄漏;对生物膜菌诱导膜去极化并破坏EPS。
临床怎么用
- PMF可作为靶向抗龋候选肽,在选择性清除变异链球菌的同时保留共生菌群。
- 亚MIC剂量下即可抑制生物膜形成,提示潜在预防应用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Dental caries, which are caused primarily by Streptococcus mutans biofilms, demand targeted antimicrobial strategies to overcome the limitations of broad-spectrum agents such as chlorhexidine (CHX). Here, we designed and synthesized a chimeric peptide (PMF) integrating three functional domains to achieve species-selective anti-microbial and anti-biofilm activities. METHODS: The antimicrobial peptides were chemically synthesized, and their biological activities were assessed. These included hemolytic and cytotoxic effects, antibacterial activity against planktonic bacteria, and antibiofilm properties. Antibacterial activity against planktonic bacteria was determined by MIC, MBC, time‑kill kinetics, and live/dead staining. Antibiofilm properties were evaluated by biofilm imaging, post‑antibiofilm effect, and crystal violet quantification. We further investigated their mechanisms of action, focusing on membrane disruption via nucleotide leakage, PI uptake, and zeta potential measurements. The damage to biofilms was also examined by assessing membrane potential and using scanning electron microscopy. RESULTS: PMF exhibited potent efficacy against S. mutans (MIC/MBC = 1.56/3.13 μM) while sparing commensals (S. sanguinis/S. gordonii MIC >100 μM). At 25 μM, a 15 min treatment inhibited 4 h biofilm growth without affecting commensal growth. Time-killing assays demonstrated the superiority of PMF over CHX. For 24 h biofilms, PMF outperforms CHX in terms of destruction efficiency and suppresses biofilm formation at sub-MIC doses. Mechanistic studies revealed that PMF employs electrostatic interactions to bind bacterial membrane lipids, which compromises membrane integrity and causes nucleic acid leakage in planktonic bacteria. For biofilm bacteria, PMF induced membrane depolarization and disrupted EPS, exposing embedded bacteria and leading to their lysis. CONCLUSIONS: This dual-targeting peptide achieves precise S. mutans elimination while maintaining microecological balance. CLINICAL SIGNIFICANCE: This work offers a promising translational framework for next-generation anti-caries therapies, enabling targeted and effective prevention and treatment approaches in clinical settings.
引用
- Wei J, Chen Z, Li S, et al. A potent dual-targeting antimicrobial peptide specifically against Streptococcus mutans biofilms. J Dent. 2026. PMID: 42025903. doi:10.1016/j.jdent.2026.106715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。